Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 14/10/2020.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques fabriquées localement :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | ROSULIP | ROSUVASTATINE | 5 mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 25/09/2020 |
2 | ROSULIP | ROSUVASTATINE | 10 mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 25/09/2020 |
3 | ROSULIP | ROSUVASTATINE | 20 mg | Comprimé pelliculé | B/30 | TERIAK | E | N | 25/09/2020 |
4 | LOWRADIP | LERCANIDIPINE | 10 mg | Comprimé pelliculé sécable | B/30 | SAIPH | E | N | 05/10/2020 |
5 | LOWRADIP | LERCANIDIPINE | 20 mg | Comprimé pelliculé sécable | B/30 | SAIPH | E | N | 05/10/2020 |
6 | DUOFOR PLUS | AMLODIPINE +VALSARTAN+ HYDROCHLOROTHIAZIDE | 5mg/160mg/12.5 mg | Comprimé pelliculé | B/30 | PHILADELPHIA PHARMA | E | N | 09/10/2020 |
7 | DUOFOR PLUS | AMLODIPINE +VALSARTAN+ HYDROCHLOROTHIAZIDE | 5mg/160mg/25 mg | Comprimé pelliculé | B/30 | PHILADELPHIA PHARMA | E | N | 09/10/2020 |
8 | DUOFOR PLUS | AMLODIPINE +VALSARTAN+ HYDROCHLOROTHIAZIDE | 10 mg/160mg/12.5mg | Comprimé pelliculé | B/30 | PHILADELPHIA PHARMA | E | N | 09/10/2020 |
9 | ORTOTON | METHOCARBAMOL | 750 mg | Comprimé pelliculé | B/20 | OPALIA PHARMA | I | N | 13/10/2020 |
10 | ORTOTON | METHOCARBAMOL | 750 mg | Comprimé pelliculé | B/50 | OPALIA PHARMA | I | N | 13/10/2020 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE Rapport |
1 | ANTIOMAL 500 | LEVETIRACETAM | 500 mg | Comprimé pelliculé | B/60 | TAHA PHARMA | E | N | 15/09/2020 |
2 | EBUVIR 400 | SOFOSBUVIR | 400 mg | Comprimé pelliculé | FL/10 | TAHA PHARMA | E | V | 22/09/2020 |
3 | EBUVIR 400 | SOFOSBUVIR | 400 mg | Comprimé pelliculé | FL/28 | TAHA PHARMA | E | V | 22/09/2020 |
4 | CUPIDON | TADALAFIL | 5 mg | Comprimé pelliculé sécable | B/30 | GALPHARMA | C | N | 22/09/2020 |
5 | CUPIDON | TADALAFIL | 10 mg | Comprimé pelliculé | B/5 | GALPHARMA | C | N | 22/09/2020 |
6 | CUPIDON | TADALAFIL | 20 mg | Comprimé pelliculé sécable | B/5 | GALPHARMA | C | N | 22/09/2020 |
7 | DIFIRAX | DEFERASIROX | 500 mg | Comprime dispersible | B/30 | IBN AL BAYTAR | V | N | 22/09/2020 |
8 | DIAMEZID | GLICLAZIDE | 60 mg | Comprimé pelliculé sécable à l | B/90 | OPALIA PHARMA | E | N | 25/09/2020 |
9 | ASPRALVIT | ACIDE ACETYLSALICYLIQUE | 1000 mg | Comprimé effervescent | B/1 tube/8 | IPS (Industrie Pharmaceutique | E | N | 29/09/2020 |
10 | ASPRALVIT C | ACIDE ACETYLSALICYLIQUE+VITAMINE C | 330mg/200mg | Comprimé effervescent | B/2 tubes/10 | IPS (Industrie Pharmaceutique | E | N | 29/09/2020 |
11 | NEOFLOXIN | CIPROFLOXACINE | 0.3% | Collyre | FL/5 ML | ADWYA | E | N | 29/09/2020 |
12 | DIAMEZID | GLICLAZIDE | 30 mg | Comprimé pelliculé à libératio | B/90 | OPALIA PHARMA | E | N | 30/09/2020 |
Spécialités Pharmaceutiques importées :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | BUTRANS | BUPRENORPHINE | 5ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
2 | BUTRANS | BUPRENORPHINE | 10ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
3 | BUTRANS | BUPRENORPHINE | 20ug/h | Dispositif transdermique | B/4 Patchs | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
4 | OXYNORM | OXYCODONE | 10mg/ml | SOL INJ | B/5/1ml | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
5 | OXYNORM | OXYCODONE | 20mg/ml | SOL INJ | B/5/2ml | Napp Pharmaceuticals Limited | V | N | 07/04/2020 |
6 | OXYCONTIN | OXYCODONE | 10mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
7 | OXYCONTIN | OXYCODONE | 15mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
8 | OXYCONTIN | OXYCODONE | 20mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
9 | OXYCONTIN | OXYCODONE | 30mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
10 | OXYCONTIN | OXYCODONE | 40mg | CP à liberation prolongée | B/20 | PURDUE PHARMA | E | N | 07/04/2020 |
11 | RAPAMUNE | SIROLIMUS | 1mg | cp enrobé | B/30 | PFIZER Europe MA EEIG | E | N | 13/04/2020 |
12 | CANCIDAS | CASPOFUNGINE | 50mg | Poudre pour prep injectable | B/1 | MSD | E | N | 17/04/2020 |
13 | CANCIDAS | CASPOFUNGINE | 70mg | Poudre pour prep injectable | B/1 | MSD | E | N | 17/04/2020 |
14 | ZYTIGA | ABIRATERONE | 250 mg | CP PEL | B/120 | Janssen-Cilag International N.V | V | V | 12/05/2020 |
15 | HERCEPTIN SOUS-CUTANE | TRASTUZUMAB | 600mg | SOL INJ | FL/5ml | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | V | N | 19/05/2020 |
16 | ACIDE ZOLEDRONIQUE MYLAN | ACIDE ZOLÉDRONIQUE | 4 MG/5 ML | SOL INJ | B/ 1FL/ 5ml | MYLAN S.A.S | E | N | 22/05/2020 |
17 | ZELBORAF | VEMURAFENIB | 240 mg | CP PEL | B/56 | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | V | N | 28/05/2020 |
18 | FASLODEX | FLUVESTRANT | 250 mg | SOL INJ | B/2/5ML | ASTRA ZENECA | V | V | 02/06/2020 |
19 | TOUJEO | INSULINE GLARGINE | 300unités/ml | SOL INJ | B/3 Stylos | SANOFI-AVENTIS Deutschland GmbH | V | N | 02/06/2020 |
20 | CYCLOGEST | PROGESTERONE | 200 MG | SUPPO | B/15 | L.D.Collins & Co.ltd | E | N | 05/06/2020 |
21 | CERTICAN | EVEROLIMUS | 0,5 MG | COMPRIME | B/60 | NOVARTIS PHARMA | V | N | 18/06/2020 |
22 | SUXAMETHONIUM CHLORID VUAB | SUXAMETHONIUM | 100 mg | PDRE PR SUS INJ | B/1FL | VUAB PHARMA AS | V | N | 26/06/2020 |
23 | AERIUS | DESLORATADINE | 0.5 mg/ml | SOL BUV | FL/150 ml | MERCK SHARP & DOHME BV | E | N | 25/06/2020 |
24 | CLARISCAN | MEGLUMINE GODATERATE | 0.5mmol/ml | SOL INJ | B/10FL/10 ML | GE HEALTHCARE AS NORVEGE | E | N | 30/06/2020 |
25 | CLARISCAN | MEGLUMINE GODATERATE | 0.5mmol/ml | SOL INJ | B/10FL/15 ML | GE HEALTHCARE AS NORVEGE | E | N | 30/06/2020 |
26 | CLARISCAN | MEGLUMINE GODATERATE | 0.5mmol/ml | SOL INJ | B/10FL/20ML | GE HEALTHCARE AS NORVEGE | E | N | 30/06/2020 |
27 | DARZALEX | DARATUMUMAB | 20mg/ml | SOL INJ | B/1FL/20ML | Janssen-Cilag International N.V | N | 02/07/2020 | |
28 | DARZALEX | DARATUMUMAB | 20mg/ml | SOL INJ | B/1FL/5ML | Janssen-Cilag International N.V | N | 02/07/2020 | |
29 | PURINETHOL | MERCAPTOPURINE | 50 MG | CP SEC | FL/25 | ASPEN PHARMA | V | V | |
30 | BRINTELLIX | VORTIOXETINE | 10 mg | COMP PEL | B/28 | H.LUNDBECK A/S | E | N | 17/07/2020 |
31 | NATEMILLE | CALCIUM+VITAMINE D3 | 600MG/1000UI | Comprimé orodispersible | B/30 | ITALFARMACO S.p.A ITALIA | E | N | 30/07/2020 |
32 | LIBLAB | EXTRAIT SEC DE FEUILLE DE LIERRE | 35.7mg | Comprimés à sucer | B/20 | DAR ALDAWA | C | N | 07/08/2020 |
33 | DROPERIDOL AGUETTANT | DROPERIDOL | 1.25 mg/ml | SOL INJ | B/10 AMP | AGUETTANT | E | N | 05/09/2020 |
34 | COSENTYX | SECUKINUMAB | 150mg/ml | SOL INJ | B/2seringues | NOVARTIS PHARMA | E | N | 15/09/2020 |
35 | COSENTYX | SECUKINUMAB | 150mg/ml | SOL INJ | B/2stylos | NOVARTIS PHARMA | E | N | 17/09/2020 |
36 | DESLORATADINE GENEPHARM | DESLORATADINE | 2,5 MG | Comprimé orodispersible | B/30 | GENEPHARM | E | N | 21/09/2020 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | PERJETA | PERTUZUMAB | 450 MG | SOL INJ | B/1 | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | E | V | CS 12/03/2020 |
2 | VIAGRA | SILDENAFIL | 50 MG | COMP | B/4 | PFIZER Europe MA EEIG | C | N | TRANSFERT 26/06/2020 |
3 | VIAGRA | SILDENAFIL | 50 MG | COMP | B/2 | PFIZER Europe MA EEIG | C | N | TRANSFERT 26/06/2020 |
4 | VIAGRA | SILDENAFIL | 50 MG | COMP | B/8 | PFIZER Europe MA EEIG | C | N | TRANSFERT 26/06/2020 |
5 | CLOMIPRAMINE MYLAN | CLOMIPRAMINE | 25 mg | COMP PEL | B/50 | MYLAN S.A.S | E | V | 08/07/2020 |
6 | JANUMET | SITAGLIPTINE+METFORMINE | 50 MG/1000 mg | COMP PEL | B/56 | MSD PAYS BAS | N | TRANSFERT 17/07/2020 | |
7 | NEXIUM 20 MG | ESOMEPRAZOLE | 20 mg | COMP | B/28 | ASTRA ZENECA UK Ltd | E | N | 22/07/2020 |
8 | TECENTRIQ | ATEZOLIZUMAB | 1200mg | SOL INJ | B/1FL/20ML | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | E | N | RE du 23/07/2020 |
9 | THYROFIX | LEVOTHYROXINE | 75µG | COMP PEL | B/30 | UNI PHARMA GRECE | E | N | RE du 03/08/2020 |
10 | THYROFIX | LEVOTHYROXINE | 25µG | COMP PEL | B/30 | UNI PHARMA GRECE | E | N | RE du 03/08/2020 |
11 | VICORAM | PERINDOPRIL ARGININE+AMLODIPINE | 7 MG/5 MG | COMP PELL | B/30 | SERVIER France | E | N | RE du 03/08/2020 |
12 | VICORAM | PERINDOPRIL ARGININE+AMLODIPINE | 7 MG/5 MG | COMP PELL | B/30 | SERVIER France | E | N | RE du 03/08/2020 |
13 | ARCHIFAR | MEROPENEME | 1 GR | PouDRE P PREPARATION INJECTABLE | b/1 fl | MEDOCHEMIE CHYPRE | E | N | RE du 11/08/2020 |
14 | ARCHIFAR | MEROPENEME | 0,5 GR | POUDRE POURPREPARATION INJECTABLE | b/1 fl | MEDOCHEMIE CHYPRE | E | N | RE du 11/08/2020 |
15 | MIRATA | ERLOTINIB | 100 MG | COMPRIME PELLICULE | B/30 | HIKMA PHARMACEUTICAL JORDANI | 28/08/2020 | ||
16 | MIRATA | ERLOTINIB | 150 MG | COMPRIME PELLICULE | B/30 | HIKMA PHARMACEUTICAL JORDANI | 28/08/2020 | ||
17 | ZYDEX B | ACIDE FUSIDIQUE + BETAMETHASONE | 2%-0,1% | CREME | T/15 G | BEIT JALA/ PALESTINE | 28/08/2020 | ||
18 | ZYDEX HC | ACIDE FUSIDIQUE + HYDROCORTISONE | 2%-1% | CREME | T/15 G | BEIT JALA/ PALESTINE | 28/08/2020 | ||
19 | SILDENAFIL MYLAN | SILDENAFIL (citrate) | 25 MG | COMPRIME PELLICULE | B/08 | MYLAN France | C | N | 22/09/2020 |
20 | SILDENAFIL MYLAN | SILDENAFIL (citrate) | 25 MG | COMPRIME PELLICULE | B/04 | MYLAN France | C | N | 22/09/2020 |
21 | SILDENAFIL MYLAN | SILDENAFIL (citrate) | 50 MG | COMPRIME PELLICULE | B/08 | MYLAN France | C | N | 22/09/2020 |
22 | SILDENAFIL MYLAN | SILDENAFIL (citrate) | 50 MG | COMPRIME PELLICULE | B/04 | MYLAN France | C | N | 22/09/2020 |
23 | SILDENAFIL MYLAN | SILDENAFIL (citrate) | 50 MG | COMPRIME PELLICULE | B/12 | MYLAN France | C | N | 22/09/2020 |
24 | SILDENAFIL MYLAN | SILDENAFIL (citrate) | 100 MG | COMPRIME PELLICULE | B/12 | MYLAN France | C | N | 22/09/2020 |
25 | SILDENAFIL MYLAN | SILDENAFIL (citrate) | 100 MG | COMPRIME PELLICULE | B/04 | MYLAN France | C | N | 22/09/2020 |
26 | SILDENAFIL MYLAN | SILDENAFIL (citrate) | 100 MG | COMPRIME PELLICULE | B/08 | MYLAN France | C | N | 22/09/2020 |
27 | D-CURE FORTE | CHOLECALCIFEROL | 100 000 UI/ML | SOLUTION BUVABLE | B/3 | SMB S.A | N | 22/09/2020 |